0001214659-19-004749.txt : 20190725
0001214659-19-004749.hdr.sgml : 20190725
20190725163012
ACCESSION NUMBER: 0001214659-19-004749
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190723
FILED AS OF DATE: 20190725
DATE AS OF CHANGE: 20190725
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Hussainy Nooshin
CENTRAL INDEX KEY: 0001685634
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37897
FILM NUMBER: 19974762
MAIL ADDRESS:
STREET 1: C/O OBALON THERAPEUTICS, INC.
STREET 2: 5421 AVENIDA ENCINAS, SUITE F
CITY: CARLSBAD
STATE: CA
ZIP: 92008
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: OBALON THERAPEUTICS INC
CENTRAL INDEX KEY: 0001427570
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 5421 AVENIDA ENCINAS
STREET 2: SUITE F
CITY: San Diego
STATE: CA
ZIP: 92008
BUSINESS PHONE: 858-480-2400
MAIL ADDRESS:
STREET 1: 5421 AVENIDA ENCINAS
STREET 2: SUITE F
CITY: San Diego
STATE: CA
ZIP: 92008
4
1
marketforms-45371.xml
PRIMARY DOCUMENT
X0306
4
2019-07-23
0001427570
OBALON THERAPEUTICS INC
OBLN
0001685634
Hussainy Nooshin
C/O OBALON THERAPEUTICS, INC.
5421 AVENIDA ENCINAS, SUITE F
CARLSBAD
CA
92008
false
true
false
false
VP of Finance
Stock Option (Right to Buy)
.96
2019-07-23
4
A
false
35000
0
A
2029-07-23
Common Stock
35000
35000
D
Subject to the grantee's continued status as a service provider with the Issuer through the applicable vesting date, the option shall vest as to 100% of the shares underlying the option on the day following the filing date of the Company's Annual Report on Form 10-K for the fiscal year ended December 31, 2019, based on the achievement of performance goals on or prior to December 31, 2019.
Share amounts do not reflect the impact of a 1-for-10 reverse stock split that became effective after the grant date for the options referenced herein.
/s/ Nooshin Hussainy
2019-07-25